Predemtec secures seed funding - MarketLine Financial Deals

Predemtec secures seed funding

Predemtec secures seed funding - MarketLine Financial Deals
Predemtec secures seed funding
Published Jul 31, 2014
2 pages — Published Jul 31, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Predemtec GmbH, a Germany-based developer of blood tests for the diagnosis of Alzheimer's disease, has secured seed funding.

  
Source:
Document ID
MA149801_140812
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Predemtec secures seed funding" Jul 31, 2014. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Predemtec-secures-seed-funding-2052-105292>
  
APA:
MarketLine Financial Deals. (2014). Predemtec secures seed funding Jul 31, 2014. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Predemtec-secures-seed-funding-2052-105292>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.